Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial

Abroad (travel likely)Recruiting

Conditions

Lymphoma · Lymphoma, Hodgkin · Lymphoma, Non-Hodgkin · Sedentary Behavior

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Christina Dieli-Conwright, MD, PhD) · ChristinaM_Dieli-Conwright@dfci.harvard.edu · 617-582-8321
Contact: Principal Investigator (Christina Dieli-Conwright, MD, PhD)

Study leads

Christina Dieli-Conwright, MD, PhD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Acute Myelogenous Leukemia · Acute Lymphatic Leukemia · Chronic Myelogenous Leukemia

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

Lymphoma · Gene Abnormality

Abroad (travel likely)Recruiting

Zhengzhou, China

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

Cardiac Imaging · Cardiac Imaging Techniques · Lymphoma

Abroad (travel likely)Recruiting

Bologna, Italy

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Lymphoplasmacytic Lymphoma · Waldenstrom Macroglobulinemia

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Tucson, United States